Each tablet contains:
Seratrodast……….. 80 mg
Seratrodast is an orally active quinone derivative and a potent TXA2 receptor antagonist used in the prophylactic management of asthma.
Seretra is indicated in prophylactic management of mild to moderate asthma.
- Hypersensitivity to Seretra or any of the ingredients
- Patients with hepatic failure
Warnings & Precautions
Seretra may lead to an elevation in the levels of the hepatic enzymes. Therefore, it has to be administered with caution in patients with hepatic impairment.